Triple antithrombotic therapy and dual therapy – What is the evidence base?
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15257
Abstract: A 78-year-old woman with atrial fibrillation (AF) and hypertension presented to the emergency department with chest pain. Her medications include amlodipine 5 mg once daily and apixaban 5 mg twice daily. The admission ECG demonstrated… read more here.
Keywords: triple antithrombotic; therapy; dual therapy; therapy evidence ... See more keywords